40 studies found for:    Open Studies | "Hypertriglyceridemia"
Show Display Options
Rank Status Study
1 Recruiting Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
Conditions: Hypertriglyceridemia;   Cutaneous T Cell Lymphoma
Intervention: Other: oral glucose tolerance test (OGTT)
2 Recruiting Hypertriglyceridaemia - Cause and Effects
Condition: Hypertriglyceridaemia
Intervention:
3 Unknown  Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia
Conditions: Hypertension;   Hypertriglyceridemia
Interventions: Dietary Supplement: DHA-EPA;   Drug: Ciprofibrate
4 Recruiting Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia
Conditions: Hyperferritinemia;   Hypertriglyceridemia
Interventions: Procedure: Phlebotomy;   Behavioral: Dietary and lifestyle counseling.
5 Not yet recruiting Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
Condition: Hypertriglyceridemia
Interventions: Drug: Omega-3-Acid Ethyl Esters 90 Soft Capsules;   Drug: Corn Oil
6 Unknown  Triglyceride Lowering Study
Condition: Hypertriglyceridemia
Intervention: Drug: Omega-3-Acid Ethyl Esters
7 Unknown  Omega-3 Fatty Acid Supplementation in Children
Conditions: Chronic Kidney Disease;   Hypertriglyceridemia
Interventions: Dietary Supplement: n-3 Fatty Acid supplement;   Dietary Supplement: Placebo
8 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Subjects With Familial Hypercholesterolemia
Conditions: Hypertriglyceridemia;   Familial Hypercholesterolemia
Interventions: Drug: IONIS ANGPTL3-LRx;   Drug: Placebo (0.9%NaCl, water, riboflavin)
9 Unknown  Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Condition: Hypertriglyceridemia
Interventions: Drug: 290 mg DCCR;   Drug: 435 mg DCCR;   Drug: 135 mg fenofibric acid;   Drug: Placebo;   Drug: atorvastatin
10 Recruiting Effect of Valedia on Glucose and Lipid Homeostasis on Subjects With Prediabetes
Conditions: Prediabetes;   Type 2 Diabetes;   Hypertriglyceridemia;   Obesity;   Disease;   Insulin Resistance
Interventions: Dietary Supplement: Valedia;   Dietary Supplement: Placebo
11 Recruiting Open-Label Study To Evaluate Efficacy, Safety, Tolerability & PK of MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects
Conditions: Non-alcoholic Steatohepatitis;   Hypertriglyceridemia;   Non-alcoholic Fatty Liver Disease
Intervention: Drug: MN-001
12 Unknown  The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)
Condition: Severe Hypertriglyceridemia
Interventions: Drug: Placebo;   Drug: SC401B 2 capsules;   Drug: SC401B 4 capsules;   Drug: SC401B 6 capsules
13 Unknown  PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Hypertriglyceridemia
Interventions: Drug: Metformin Eicosapentaenoate;   Drug: Metformin HCl and Vascepa
14 Unknown  Bioavailability of EPA and DHA From Two Dietary Supplements
Condition: Hypertriglyceridemia
Intervention: Dietary Supplement: DHA-rich fish oil versus Phospholipid-rich fish oil
15 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Intervention: Other: Omega diet
16 Recruiting Effects of DPP-4 Inhibition on Triglycerides
Conditions: Type 2 Diabetes;   Hypertriglyceridemia
Intervention: Drug: Saxagliptin
17 Unknown  Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)
18 Recruiting Maternal Hypertriglyceridaemia Study
Condition: Metabolic Syndrome X
Intervention: Procedure: Blood sampling
19 Recruiting Orlistat for the Treatment of Type I Hyperlipoproteinemia
Conditions: Hyperlipoproteinemia Type I;   Hypertriglyceridemia
Intervention: Drug: Orlistat
20 Recruiting A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Condition: Hypertriglyceridemia
Interventions: Drug: Drug Omega 3;   Drug: Drug Omega-3 Comparator

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years